Dataset from A Phase 1, Open-label Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB074 and to Assess the Effect of Food on BIIB074 Pharmacokinetics in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009318
下载链接
链接失效反馈官方服务：
资源简介：
The primary objectives of the study are to assess the relative bioavailability of the BIIB074
direct compression formulation (DCF) to the BIIB074 roller compaction formulation (RCF) and
to determine the effect of a high-fat meal on the pharmacokinetics (PK) of the BIIB074 DCF.
The secondary objective of the study is to assess the safety and tolerability of BIIB074
administered as the DCF following single oral dose administration in healthy participants.
创建时间：
2025-07-07
